🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
FAQ|Rules|Members
Log In Register
Forums›Clinical Trials & Research

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards

Clinical Trials & Research

134 threads · 1.7K posts
TM
Pinned ClinicalTrials.gov GLP-1 trial tracker — updated weekly
TrialTracker_MD · Dec 2, 2023
75Replies
58KViews
TM
TrialTracker_MD
Dec 2, 2023
D
Study FLOW trial: semaglutide renal outcomes — NEJM publication review
Dr.RenalNash · Today at 2:04 AM
14Replies
266Views
D
Dr.RenalNash
Today at 2:04 AM
D
Study SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data
Dr.CardioMD · Today at 12:22 AM
9Replies
160Views
D
Dr.CardioMD
Today at 12:22 AM
TM
Study TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints
TrialTracker_MD · Yesterday at 7:40 PM
13Replies
202Views
TM
TrialTracker_MD
Yesterday at 7:40 PM
TM
Study Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist
TrialTracker_MD · Yesterday at 11:59 AM
8Replies
130Views
TM
TrialTracker_MD
Yesterday at 11:59 AM
D
Study CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results
Dr.Martinez · Yesterday at 1:19 AM
20Replies
606Views
D
Dr.Martinez
Yesterday at 1:19 AM
MS
Study Survodutide (GCG/GLP-1) — MASH and obesity trial results
MASHdoc_SA · Thursday at 11:40 AM
16Replies
467Views
MS
MASHdoc_SA
Thursday at 11:40 AM
MS
Study Pemvidutide Phase 2 — NAFLD endpoints
MASHdoc_SA · Wednesday at 7:01 PM
20Replies
520Views
MS
MASHdoc_SA
Wednesday at 7:01 PM

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
D
Study STEP-HFpEF: semaglutide in heart failure with preserved EF
Dr.CardioMD · Tuesday at 11:24 PM
15Replies
386Views
D
Dr.CardioMD
Tuesday at 11:24 PM
TM
Study Ecnoglutide, mazdutide, and other emerging GLP-1 pipeline agents
TrialTracker_MD · Tuesday at 12:47 AM
19Replies
418Views
TM
TrialTracker_MD
Tuesday at 12:47 AM
D
Study SOUL trial: semaglutide cardiovascular outcomes in T2DM — design overview
Dr.CardioMD · Sunday at 11:11 PM
14Replies
318Views
D
Dr.CardioMD
Sunday at 11:11 PM
TB
Study Amycretin (Novo Nordisk) — amylin/GLP-1 co-agonist Phase 1 data
TrialNerd_Beth · Saturday at 6:36 PM
9Replies
247Views
TB
TrialNerd_Beth
Saturday at 6:36 PM
TB
Study Mazdutide (LY3305677) — GLORY trials in Chinese population
TrialNerd_Beth · Mar 6, 2026
14Replies
547Views
TB
TrialNerd_Beth
Mar 6, 2026
TM
Guide Phase 3 trial enrollment guide — how to participate in GLP-1 studies
TrialTracker_MD · Mar 5, 2026
10Replies
430Views
TM
TrialTracker_MD
Mar 5, 2026
SI
New SURMOUNT-MMO: tirzepatide for morbid obesity — trial update
SurmountFan_IN · Mar 3, 2026
11Replies
436Views
SI
SurmountFan_IN
Mar 3, 2026
123…9
Users browsing this forum: Admin, Dr.Martinez, mike_mod, sarah.morrison, TirzTom, JennaRN and 23 guests
CompoundTalk Weekly Digest

Top threads, new research, and vendor alerts every Friday.

ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register